VRHI (Veri Medtech Holdings) LT-Debt-to-Total-Asset: 0.00 (As of Dec. 2021)


VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $1.95
View Full Analysis

What is Veri Medtech Holdings LT-Debt-to-Total-Asset?

Veri Medtech Holdings VRHI 35 LT-Debt-to-Total-Asset is 0.00 as of Dec. 2021. GuruFocus rates VRHI with a GF Score™ of 35/100.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Veri Medtech Holdings's long-term debt to total assests ratio for the quarter that ended in Dec. 2021 was 0.00.

Veri Medtech Holdings's long-term debt to total assets ratio stayed the same from . 20 (0.00) to Dec. 2021 (0.00).

Veri Medtech Holdings  (OTCPK:VRHI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Veri Medtech Holdings LT-Debt-to-Total-Asset Related Terms

Veri Medtech Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings LT-Debt-to-Total-Asset Chart

Veri Medtech Holdings Annual Data
Trend Dec21
LT-Debt-to-Total-Asset
0.00

Veri Medtech Holdings Semi-Annual Data
Dec21
LT-Debt-to-Total-Asset 0.00
VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings LT-Debt-to-Total-Asset Calculation

Veri Medtech Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (A: Dec. 2021 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2021 )/Total Assets (A: Dec. 2021 )
=0/0.35
=0.00

Veri Medtech Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (Q: Dec. 2021 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2021 )/Total Assets (Q: Dec. 2021 )
=0/0.35
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Veri Medtech Holdings (VRHI) has a LT-Debt-to-Total-Asset of 0.00 as of Dec. 2021. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' LT-Debt-to-Total-Asset too high?
Veri Medtech Holdings' current LT-Debt-to-Total-Asset is 0.00. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' LT-Debt-to-Total-Asset compare to MMVVF and BLMZ?
Veri Medtech Holdings' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?
A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Veri Medtech Holdings and its competitors. Veri Medtech Holdings's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current LT-Debt-to-Total-Asset is 0.00 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price